Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
linear decrease » linear increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
linear decrease » linear increase (Expand Search)
-
2981
-
2982
-
2983
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2984
-
2985
-
2986
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2987
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2988
-
2989
-
2990
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2991
-
2992
-
2993
-
2994
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2995
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2996
-
2997
-
2998
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2999
-
3000